152 related articles for article (PubMed ID: 38701029)
21. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
Wilson L; Turkistani FA; Huang W; Tran DM; Lin TK
PLoS One; 2018; 13(5):e0197449. PubMed ID: 29799850
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of Specialty Drug Price Trends Using Data from Retrospective Pharmacy Sales Transactions.
Penington R; Stubbings JA
J Manag Care Spec Pharm; 2016 Sep; 22(9):1010-7. PubMed ID: 27574742
[TBL] [Abstract][Full Text] [Related]
23. Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy.
Petry L; Zuckerman AD; DeClercq J; Choi L; Lynch B; Saknini M
J Manag Care Spec Pharm; 2023 Jul; 29(7):732-739. PubMed ID: 37404072
[No Abstract] [Full Text] [Related]
24. Outcomes of a pharmacist-managed medication refill program.
Billups SJ; Delate T; Newlon C; Schwiesow S; Jahnke R; Nadrash A
J Am Pharm Assoc (2003); 2013; 53(5):505-12. PubMed ID: 24030128
[TBL] [Abstract][Full Text] [Related]
25. Pharmaceutical pricing benchmarks: governmental versus private sector.
Turkistani F; Sawad AB
J Comp Eff Res; 2020 Oct; 9(15):1091-1100. PubMed ID: 33052057
[No Abstract] [Full Text] [Related]
26. A prospective trial of a clinical pharmacy intervention in a primary care practice in a capitated payment system.
Altavela JL; Jones MK; Ritter M
J Manag Care Pharm; 2008; 14(9):831-43. PubMed ID: 19006440
[TBL] [Abstract][Full Text] [Related]
27. Comparison of prescription reimbursement methodologies in Japan and the United States.
Akaho E; MacLaughlin EJ; Takeuchi Y
J Am Pharm Assoc (2003); 2003; 43(4):519-26. PubMed ID: 12952317
[TBL] [Abstract][Full Text] [Related]
28. Impact of health system specialty pharmacies on total cost of care in cancer treatment, a multisite review.
Wink S; Schroader BK; Giglio T; Ward A
J Oncol Pharm Pract; 2024 Jul; 30(5):884-892. PubMed ID: 37649402
[TBL] [Abstract][Full Text] [Related]
29. Association between dispensing channel and medication adherence among medicare beneficiaries taking medications to treat diabetes, high blood pressure, or high blood cholesterol.
Iyengar RN; Balagere DS; Henderson RR; LeFrancois AL; Rabbitt RM; Frazee SG
J Manag Care Spec Pharm; 2014 Aug; 20(8):851-61. PubMed ID: 25062079
[TBL] [Abstract][Full Text] [Related]
30. Droxidopa management by an integrated health-system specialty pharmacy team.
Livezey SN; Shah NB; DeClercq J; Keefe J; Choi L; Shibao C; Zuckerman AD
J Am Pharm Assoc (2003); 2022; 62(6):1904-1911. PubMed ID: 35787811
[TBL] [Abstract][Full Text] [Related]
31. Comparison of rates of adherence to oral chemotherapy medications filled through an internal health-system specialty pharmacy vs external specialty pharmacies.
McCabe CC; Barbee MS; Watson ML; Billmeyer A; Lee CE; Rupji M; Chen Z; Haumschild R; El-Rayes B
Am J Health Syst Pharm; 2020 Jul; 77(14):1118-1127. PubMed ID: 32537656
[TBL] [Abstract][Full Text] [Related]
32. Improvement in safety monitoring of biologic response modifiers after the implementation of clinical care guidelines by a specialty.
Hanson RL; Gannon MJ; Khamo N; Sodhi M; Orr AM; Stubbings J
J Manag Care Pharm; 2013; 19(1):49-67. PubMed ID: 23383700
[TBL] [Abstract][Full Text] [Related]
33. Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy.
Bekker CL; Melis EJ; Egberts ACG; Bouvy ML; Gardarsdottir H; van den Bemt BJF
Res Social Adm Pharm; 2019 Jan; 15(1):100-105. PubMed ID: 29610051
[TBL] [Abstract][Full Text] [Related]
34. Impact of Clinical Pharmacy Surveillance on Pharmacy Services: A Quality Improvement Project.
Kramer JS; Borum C; Claxon EL; Wines KJ; Fraker S; Burgess LH
J Healthc Manag; 2023 Sep-Oct 01; 68(5):312-324. PubMed ID: 37678824
[TBL] [Abstract][Full Text] [Related]
35. Clinical Pharmacy Services in a Multidisciplinary Specialty Pain Clinic.
Semerjian M; Durham MJ; Mirzaian E; Lou M; Richeimer SH
Pain Pract; 2019 Mar; 19(3):303-309. PubMed ID: 30403432
[TBL] [Abstract][Full Text] [Related]
36. Impact of a Clinical Pharmacist-Managed Medication Refill Clinic.
Nguyen M; Zare M
J Prim Care Community Health; 2015 Jul; 6(3):187-92. PubMed ID: 25653044
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Economic Benefits of Pharmacist Involvement in a Community Hospital-Affiliated Patient-Centered Medical Home.
Tate ML; Hopper S; Bergeron SP
J Manag Care Spec Pharm; 2018 Feb; 24(2):160-164. PubMed ID: 29384022
[TBL] [Abstract][Full Text] [Related]
38. Addressing the Challenges of Novel Oncology and Hematology Treatments Across Sites of Care: Specialty Pharmacy Solutions.
Wyatt H; Zuckerman AD; Hughes ME; Arnall J; Miller R
J Oncol Pharm Pract; 2022 Apr; 28(3):627-634. PubMed ID: 35037778
[No Abstract] [Full Text] [Related]
39. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP).
Perera PN; Guy MC; Sweaney AM; Boesen KP
J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804
[TBL] [Abstract][Full Text] [Related]
40. Adherence to oral anticancer chemotherapies and estimation of the economic burden associated with unused medicines.
Matti N; Delon C; Rybarczyk-Vigouret MC; Khan GM; Beck M; Michel B
Int J Clin Pharm; 2020 Oct; 42(5):1311-1318. PubMed ID: 32857257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
